Is Procalcitonin Useful in Pediatric Critical Care Patients?
This review examines the use of procalcitonin in different clinical situations in the pediatric patient, with special emphasis on those requiring intensive care. We review the latest articles on its potency as a biomarker in both infectious processes at diagnosis and on the response to treatment.
Main Authors: | Sara Bobillo-Perez, Javier Rodríguez-Fanjul, Iolanda Jordan Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-08-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.1177/1177271918792244 |
Similar Items
-
Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation
by: Sara Bobillo, et al.
Published: (2018-01-01) -
Procalcitonin and lung ultrasound algorithm to diagnose severe pneumonia in critical paediatric patients (PROLUSP study). A randomised clinical trial
by: Javier Rodríguez-Fanjul, et al.
Published: (2020-10-01) -
Procalcitonin is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The Prokineca Study
by: Sara Bobillo Pérez, et al.
Published: (2016-01-01) -
Procalcitonin Is a Better Biomarker than C-Reactive Protein in Newborns Undergoing Cardiac Surgery: The PROKINECA Study
by: Sara Bobillo Pérez, et al.
Published: (2016-11-01) -
Procalcitonin to stop antibiotics after cardiovascular surgery in a pediatric intensive care unit-The PROSACAB study.
by: Sara Bobillo-Perez, et al.
Published: (2019-01-01)